Neuropeptide FF receptor 1

Neuropeptide FF receptor 1 (NPFFR1), also known as G-protein coupled receptor 147 (GPR147), is a protein that in humans is encoded by the NPFFR1 gene. This receptor is a member of the G protein-coupled receptor (GPCR) family, which plays a critical role in signal transduction within cells and mediates various physiological processes. NPFFR1 is predominantly involved in the modulation of pain and analgesic response, acting primarily in the central nervous system. It binds neuropeptides, including Neuropeptide FF (NPFF), which is a part of the RF-amide peptide family.

Function

NPFFR1 is implicated in several critical physiological roles, including the modulation of opioid signaling pathways, which affects pain perception and analgesic responses. The receptor is also involved in the regulation of hormone release and may play a role in feeding behavior. The interaction between NPFFR1 and its ligands is known to modulate the analgesic effects of opioids, suggesting a complex interplay between NPFFR1 signaling and opioid receptor systems. This interaction is of particular interest in the development of new analgesic drugs that could potentially enhance pain relief while mitigating opioid-induced side effects.

Distribution

The expression of NPFFR1 is primarily localized to the central nervous system, including regions such as the hypothalamus and spinal cord, which are key areas involved in pain perception and the regulation of feeding behavior. Its presence in these areas underlines the receptor's significance in neurophysiological processes.

Clinical Significance

Given its role in pain modulation and the opioid system, NPFFR1 is a target of interest for the development of novel analgesic compounds. Drugs targeting NPFFR1 could offer new avenues for pain management, potentially with fewer side effects compared to traditional opioids. Furthermore, understanding the receptor's function could also shed light on mechanisms underlying various neurological and psychiatric disorders, offering potential targets for therapeutic intervention.

Research Directions

Research on NPFFR1 is ongoing, with studies focusing on elucidating its precise mechanisms of action, its interactions with other signaling pathways, and its potential as a therapeutic target. The development of selective agonists and antagonists for NPFFR1 is a key area of interest, which could lead to new treatments for pain and other conditions.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian